CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Association of Cardiovascular Disease With Respiratory Disease Modifiable lifestyle factors and heart failure: A Mendelian randomization study Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome? Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past? Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

Original Research2015 Jan 20;131(3):269-79.

JOURNAL:Circulation. Article Link

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Shah SJ, Katz DH, Selvaraj S et al. Keywords: cluster analysis; echocardiography; heart failure, diastolic; patient outcome assessment

FULL TEXT PDF